MAS A.G. SA
MAS A.G. reported total assets of €34.7m at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Aug 2026).
The score of MAS A.G. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -46 % Total assets -37 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MAS A.G.'s annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Aug 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 25 Sep 2024
- Year ended 31 Dec 2022filed on 25 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
MAS A.G.'s financial analysis
- Solvency85.3%sector median: 42.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MAS A.G.
MAS A.G.'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0818.817.283
- VAT number
- BE0818817283
- Peppol
- Registered · 0208:0818817283 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 21 Sep 2009
- Registered office
- 4780 Sankt Vith
- Latest accounts
- 2025 · filed on 21 Aug 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
MAS A.G. (SA) has been based in Sankt Vith since 2009, active in: manufacture of other pharmaceutical products. For 2025, it reports a net profit of €17.8m and equity of €29.6m; its revenue is not published. Its solvency stands at 85.3%, above the median of its sector (42.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to MAS A.G.
Companies in the same business, of comparable size and area, outside its group.
- Bio Minerals Manufacture of basic pharmaceutical products Destelbergen · balance sheet €17.7m
- Medigroup Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €30.2m
- H & H Pharmaceuticals Wholesale of pharmaceutical and medical goods Nivelles · balance sheet €47.4m
- ABC Dental and Pharmaceutical Consultancy Wholesale of pharmaceutical and medical goods Nazareth-De Pinte · balance sheet €36.0m
- Pharma Flex Manufacture of other general-purpose machinery n.e.c. Nivelles · balance sheet €14.3m
- Hyloris Pharmaceuticals Activities of holding companies Liège · balance sheet €101.5m
- V!GO International Activities of head offices Wetteren · balance sheet €105.2m
- Besins Healthcare Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €110.7m
Frequently asked questions about MAS A.G.
What is the revenue of MAS A.G.?
MAS A.G. files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MAS A.G.?
In Belgium, the VAT number is the company number prefixed with BE: BE0818817283 for MAS A.G., if the company is VAT-registered. Its company number (CBE) is 0818.817.283.
Where is the registered office of MAS A.G.?
According to the CBE register, the registered office of MAS A.G. is in 4780 Sankt Vith.
What is the equity of MAS A.G.?
At the close of the 2025 financial year, the equity of MAS A.G. amounts to 29,580,465 €, a solvency of 85.3% of total assets.
Who manages MAS A.G.?
The register lists 3 active mandates at MAS A.G.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MAS A.G.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →